Cargando…

Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice

Isorhamnetin (IRh), which has a wide range of pharmacological effects, is one of the most significant active components in the fruits of Hippophae rhamnoides L. and the leaves of Ginkgo biloba L. It protects the heart and brain, in addition to possessing anti-tumor, anti-inflammatory, antioxidant, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chieh-Shan, Lin, Chuan-Chao, Chen, Yu-Ying, Yang, Deng-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786590/ https://www.ncbi.nlm.nih.gov/pubmed/36556472 http://dx.doi.org/10.3390/life12122107

Ejemplares similares

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020)

Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis
por: Giacomassi, Chiara, et al.
Publicado: (2017)

Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Li, Fei, et al.
Publicado: (2022)

CB2R Deficiency Exacerbates Imiquimod-Induced Psoriasiform Dermatitis and Itch Through the Neuro-Immune Pathway
por: Li, Li, et al.
Publicado: (2022)

A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice
por: Griffith, Alexis D., et al.
Publicado: (2018)

Signs of chronic itch in the mouse imiquimod model of psoriasiform dermatitis: sex differences and roles of TRPV1 and TRPA1
por: Follansbee, Taylor, et al.
Publicado: (2019)

Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice
por: Horváth, Szabina, et al.
Publicado: (2019)

Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod‐induced, psoriasiform dermal inflammation in mice
por: Zhou, Yan, et al.
Publicado: (2019)

Chitosan-based nanoformulated (−)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
por: Chamcheu, Jean Christopher, et al.
Publicado: (2018)

MAPK Phosphatase-1 Deficiency Exacerbates the Severity of Imiquimod-Induced Psoriasiform Skin Disease
por: Zhao, Weiheng, et al.
Publicado: (2018)

Gain-of-function of TRPM4 predisposes mice to psoriasiform dermatitis
por: Yamada, Daisuke, et al.
Publicado: (2022)

2′-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice
por: Hao, Lihua, et al.
Publicado: (2021)

Chitosan-Based Nanoformulated (–)-Epigallocatechin-3-Gallate (EGCG) Modulates Human Keratinocyte-Induced Responses and Alleviates Imiquimod-Induced Murine Psoriasiform Dermatitis [Erratum]
Publicado: (2023)

Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation
por: Nakahara, Takeshi, et al.
Publicado: (2020)

Psoriasiform Dermatitis in a COVID-19 Patient
por: Wu, Marlyn, et al.
Publicado: (2022)

Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Chen, Hsin-Hua, et al.
Publicado: (2020)

IL-1R1 signaling facilitates Munro’s microabscess formation in psoriasiform imiquimod-induced skin inflammation
por: Uribe-Herranz, Mireia, et al.
Publicado: (2013)

Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling
por: Zhang, Bin, et al.
Publicado: (2016)

Pivotal role of CD103 in the development of psoriasiform dermatitis
por: Fukui, Takehito, et al.
Publicado: (2020)

Systemic Psoriasiform Dermatitis Appeared after the Administration of Pembrolizumab
por: Suzuki, Manabu, et al.
Publicado: (2019)

Relapsed angioimmunoblastic T-cell lymphoma presenting as psoriasiform dermatitis
por: McClure, Spencer, et al.
Publicado: (2023)

Anti-Obesity Effects of Isorhamnetin and Isorhamnetin Conjugates
por: González-Arceo, Maitane, et al.
Publicado: (2022)

DERMAL VASCULATURE IN PSORIASIS AND PSORIASIFORM DERMATITIS: A MORPHOMETRIC STUDY
por: Gupta, Shilpa, et al.
Publicado: (2011)

Phenotypic changes of lymphocyte populations in psoriasiform dermatitis animal model
por: Surcel, Mihaela, et al.
Publicado: (2019)

Reinforcing involvement of NK cells in psoriasiform dermatitis animal model
por: Surcel, Mihaela, et al.
Publicado: (2019)

Augmentation of NAD(+) by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Lee, Seung Hoon, et al.
Publicado: (2022)

Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel
por: He, Xiang, et al.
Publicado: (2020)

Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis
por: Bezdek, Siegfried, et al.
Publicado: (2018)

Clinical Psoriasiform Dermatitis Following Dupilumab Use for Autoeczematization Secondary to Chronic Stasis Dermatitis
por: Schrom, Kory P, et al.
Publicado: (2020)

Granulocyte Colony-Stimulating Factor-Induced Psoriasiform Dermatitis Improved by Narrowband Ultraviolet B
por: Jang, Min Soo, et al.
Publicado: (2017)

Author Correction: Pivotal role of CD103 in the development of psoriasiform dermatitis
por: Fukui, Takehito, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Psoriasiform, Spongiotic, and Lichenoid Dermatitis: A Novel Clinicopathological Pattern
por: Kost, Yana, et al.
Publicado: (2022)

CCR6 is required for epidermal trafficking of γδ T cells in an IL-23-induced model of psoriasiform dermatitis
por: Mabuchi, Tomotaka, et al.
Publicado: (2012)

A Case of Adalimumab-Induced Psoriasiform Dermatitis in an Ankylosing Spondylitis Patient: Unusual Progression after Adalimumab Retreatment
por: Yoon, Ji Ha, et al.
Publicado: (2022)

Electrophilic nitro-fatty acids suppress psoriasiform dermatitis: STAT3 inhibition as a contributory mechanism
por: Wang, Peng, et al.
Publicado: (2021)

Antipsoriatic Effects of Wannachawee Recipe on Imiquimod-Induced Psoriasis-Like Dermatitis in BALB/c Mice
por: Na Takuathung, Mingkwan, et al.
Publicado: (2018)

Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients
por: Yen, Ling-Jung, et al.
Publicado: (2022)

Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
por: Augustin, Iris, et al.
Publicado: (2013)

Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice
por: Chen, Yi-Hsing, et al.
Publicado: (2016)

CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis
por: Takekoshi, Tomonori, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rdr2a9b9gqp018m6gt3coj2j4j